Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02186652Phase 1Completed
Phase 1, open-label trial of pantoprazole in gastroesophageal reflux disease (GERD). Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02186652.